Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 8, 2003
Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF)V G Nicoletti, R Nicoletti, N Ferrara, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1993
Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infectionsA M Lo Bue, R Sammartino, G Chisari, et al.
La Clinica Terapeutica|January 1, 1992
[The effect of Lactobacillus acidophilus and Bifidobacterium bifidum on the intestinal ecosystem of the elderly patient]G Pecorella, E Vasquez, M R Gismondo, et al.
Expert Opinion on Pharmacotherapy|May 16, 2019
Pharmacoeconomics of synthetic therapies for multiple sclerosisEmanuele D'Amico, Clara G Chisari, Lara Gitto, et al.
Giornale Italiano Di Chemioterapia|January 1, 1992
[Adhesion capacity of Enterococcus faecium (SF 68) and Enterococcus faecalis to various substrates]G Chisari, A M Lo Bue, L Drago, et al.
Eye (London, England)|September 17, 2013
Evaluation of retinal nerve fiber layer and ganglion cell complex thickness after ocular blunt traumaG Cennamo, R Forte, M Reibaldi, et al.
Expert Opinion on Pharmacotherapy|April 29, 2020
An update on the pharmacological management of pain in patients with multiple sclerosisClara G Chisari, Eleonora Sgarlata, Sebastiano Arena, et al.
Multiple Sclerosis and Related Disorders|September 18, 2018
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance ManagerV Cimino, C G Chisari, G Raciti, et al.
Expert Review of Clinical Pharmacology|March 10, 2018
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experienceE D'Amico, F Patti, A Zanghì, et al.
European Journal of Neurology|June 30, 2018
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up studyE D'Amico, F Patti, A Zanghì, et al.
Pageof 7